NCT02646072View on ClinicalTrials.gov

Effect of Preoperative Topical Ketorolac on Aqueous Cytokine Levels and Macular Thickness in Cataract Surgery Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

June 30, 2015

Conditions
Cystoid Macular Edema, PostoperativeDiabetes Mellitus
Interventions
DRUG

Ketorolac tromethamine ophthalmic solution 0.45%

Indicated for the treatment of pain and inflammation following cataract surgery.

Trial Locations (1)

50603

University of Malaya, Kuala Lumpur

All Listed Sponsors
lead

University of Malaya

OTHER

NCT02646072 - Effect of Preoperative Topical Ketorolac on Aqueous Cytokine Levels and Macular Thickness in Cataract Surgery Patients | Biotech Hunter | Biotech Hunter